National Pharmaceutical Council and Discern Health Outline Strategies for Improving Patient-Reported Measures in Oncology

February 2019

(Washington, DC, February 21, 2019) – The National Pharmaceutical Council (NPC) and Discern Health today released a study that analyzes the landscape of available patient-reported measures (PRMs) and patient-reported performance measures (PR-PMs) in oncology and offers recommendations for filling gaps in measures and removing barriers to measure implementation. The study, “Improving Patient-reported Measures in Oncology,” builds on previous work to close gaps in quality measurement and focuses on the importance of patient input in accountable care.

Click here to view the full press release.

New Report: Recommendations for Patient and Family Engagement in Measure Development

Harnessing the stories, ideas, and innovations of patient and caregiver partners is the key to making measurement meaningful. With support from the Patient-Centered Outcomes Research Institute (PCORI)...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO